About: Covidien   Sponge Permalink

An Entity of Type : owl:Thing, within Data Space : 134.155.108.49:8890 associated with source dataset(s)

"Covidien is: * A large global healthcare company committed to sustaining strong margins and cash flows while making investments for growth * A leading manufacturer of medical devices and supplies, diagnostic imaging agents and pharmaceuticals, with 2007 revenue of nearly $9 billion and industry-leading profit margins * 42,000 employees strong in more than 130 countries worldwide with an expanding presence in emerging markets around the world * Dedicated to R&D, spending more than $250 million in R&D during 2007 alone, with that amount expected to increase in 2008 * Committed to creating innovative medical solutions for better patient outcomes and delivering value through clinical leadership and excellence "

AttributesValues
rdfs:label
  • Covidien
rdfs:comment
  • "Covidien is: * A large global healthcare company committed to sustaining strong margins and cash flows while making investments for growth * A leading manufacturer of medical devices and supplies, diagnostic imaging agents and pharmaceuticals, with 2007 revenue of nearly $9 billion and industry-leading profit margins * 42,000 employees strong in more than 130 countries worldwide with an expanding presence in emerging markets around the world * Dedicated to R&D, spending more than $250 million in R&D during 2007 alone, with that amount expected to increase in 2008 * Committed to creating innovative medical solutions for better patient outcomes and delivering value through clinical leadership and excellence "
sameAs
dcterms:subject
abstract
  • "Covidien is: * A large global healthcare company committed to sustaining strong margins and cash flows while making investments for growth * A leading manufacturer of medical devices and supplies, diagnostic imaging agents and pharmaceuticals, with 2007 revenue of nearly $9 billion and industry-leading profit margins * 42,000 employees strong in more than 130 countries worldwide with an expanding presence in emerging markets around the world * Dedicated to R&D, spending more than $250 million in R&D during 2007 alone, with that amount expected to increase in 2008 * Committed to creating innovative medical solutions for better patient outcomes and delivering value through clinical leadership and excellence "
Alternative Linked Data Views: ODE     Raw Data in: CXML | CSV | RDF ( N-Triples N3/Turtle JSON XML ) | OData ( Atom JSON ) | Microdata ( JSON HTML) | JSON-LD    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3217, on Linux (x86_64-pc-linux-gnu), Standard Edition
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2012 OpenLink Software